This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dehaier Medical Announces Strategic Mutual Cooperation Agreement With HEYER Medical AG





BEIJING, June 18, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that the Company has entered into a three-year strategic mutual cooperation agreement with HEYER Medical AG ("Heyer"), an internationally recognized, Germany-based company specializing in state-of-the-art inhalation and anesthesia equipment, oxygen concentrators, breathing therapy equipment and connecting equipment. Management of both parties participated in the signing ceremony at Dehaier's headquarters in Beijing on June 5, 2012.

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO)

According to the Agreement, Dehaier will continue to be one of the key distributors for Heyer's anesthesia machines and exclusive distributor of nebulizers in China. Heyer's anesthesia machines and inhalation equipment currently holds a large market share in China, and Dehaier believes that there are a number of significant growth opportunities for Heyer's products throughout the country.  As Heyer's distributor, Dehaier will continue leveraging its solid professional sales force and strong customer base to promote and market Heyer's products. In addition to distributing Heyer's products in China, Dehaier will also provide medical products and technical services for Heyer, delivering high quality, cost-effective products to the majority of countries that Heyer serves, predominantly in Asia, East Asia and Africa.

Dehaier's CEO, Mr. Ping Chen stated, "We continue to build long-lasting relationships with many of the industry's most renowned medical manufacturers. I met with Mr. Klaus Schickhaus, CEO of Heyer Medical in Beijing last year, and he also showed great interest in Dehaier's homecare market portfolio and is reviewing opportunities for potential joint cooperation. We are delighted to be working with Heyer and welcome this opportunity for Dehaier to strengthen our international market expansion, enhance our brand awareness, improve our R&D capability, and eventually realize substantial growth in revenue for the benefit of our shareholders."

About Heyer Medical

Founded in 1883, Heyer became an innovator in inhalation technology for the treatment of respiratory tract diseases. Today Heyer is an internationally acknowledged specialist in state-of-the-art inhalation and anesthesia equipment, oxygen concentrators, breathing therapy equipment and connecting equipment. The products are used all over the world, particularly in the medical field, in clinics and practices in Europe and Asia as well as in the Middle East, South America and the USA. Their inhalation equipment is also increasingly used in wellness applications and for treatment and care at home.



1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs